Baricitinib (Olumiant) would be the first JAK inhibitor (and oral medicine) indicated for adults with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.
International Approvals
…read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
